References

Summary of previous project experience

  • Allergic rhinitis (antihistamines)
  • Arthritis (diclofenac)
  • Rheumatoid arthritis (DMARDs)
  • Osteoarthritis
  • Bronchial asthma (MDIs)
  • Dementia (anti-dementia medications)
  • Depression (antidepressants)
  • Diabetes mellitus (insulin, oral antidiabetics)
  • Epilepsy (antiepileptics)
  • Erectile dysfunction (PDE) inhibitors
  • Haemophilia B (coagulation factors)
  • Hepatitis B and C (interferons)
  • Heart failure (PDE inhibitors)
  • HIV (antivirals)
  • Hormone replacement therapy
  • Hyperlipidaemia (LDL-apheresis)
  • Hypertension (antihypertensives)
  • Infections (anti-infectives)
  • CHD (cardiac therapeutics)
  • Contraception (oral contraceptives)
  • Local anaesthesia
  • MS (immunomodulators)
  • Neurodermatitis (glucocorticoids)
    Oesophageal varices (vasodilators)
  • Opiate addiction (substitution therapy)
  • Osteoporosis (bisphosphonates)
  • Parenteral nutrition
  • Nasal polyps (glucocorticoids)
  • Benign prostatic hypertrophy (alpha-blockers)
  • Prostate cancer (antiandrogens)
  • Thrombophilia (epidemiology)
  • Venous thrombosis (heparin)
  • Cytostatic-induced nausea (5-HT3 antagonists)